Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ResMed (RMD)

ResMed dismisses KPMG, appoints PwC as auditor; director Ron Taylor to retire

Neutral Impact 3 of 5 leadership Written later

ResMed dismissed KPMG as its independent auditor on August 13, 2026, and appointed PricewaterhouseCoopers for the fiscal year ending June 30, 2027, subject to PwC's client acceptance procedures. The filing also reports that director Ron Taylor will not stand for reelection and will retire at the November 18, 2026 annual meeting, with Carol Burt named lead director effective November 15, 2026.

Key points

  • KPMG's reports on the fiscal 2026 and 2025 financial statements contained no adverse opinion, disclaimer, or qualification, and the filing reports no disagreements or reportable events.
  • PwC appointed on August 13, 2026, following a competitive review by the Audit Committee, subject to completion of its standard client acceptance procedures.
  • Ron Taylor, a director since 2005 and lead director since 2013, is retiring at the 2026 Annual Meeting on November 18, 2026, and his retirement is not due to any disagreement with the company.
  • Carol Burt, a Board member since 2013 who chairs the Nominating and Governance Committee, becomes lead director on November 15, 2026.

The filing

CompanyResMed (RMD)
Form8-K, current report
Filed with the SECAug 17, 2026, 4:30 PM ET
Accession number0001193125-26-354154

Items reported: 4.01 Auditor Change5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.